AI assistant
CLEO DIAGNOSTICS LTD — Share Issue/Capital Change 2025
Dec 28, 2025
64689_rns_2025-12-28_21f1e506-d223-455b-81d1-8f8de1d03406.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Appendix 2A - Application for quotation of securities
==> picture [21 x 22] intentionally omitted <==
Announcement Summary
Entity name
CLEO DIAGNOSTICS LTD
Announcement Type
New announcement
Date of this announcement
Monday December 29, 2025
The +securities to be quoted are:
+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted
Total number of +securities to be quoted
| ASX +security | Number of +securities to | ||
|---|---|---|---|
| code | Security description | be quoted | Issue date |
| COV | ORDINARY FULLY PAID | 28,750 | 29/12/2025 |
Refer to next page for full details of the announcement
Appendix 2A - Application for quotation of securities
1 / 6
Appendix 2A - Application for quotation of securities
Part 1 - Entity and announcement details
==> picture [21 x 22] intentionally omitted <==
1.1 Name of entity
CLEO DIAGNOSTICS LTD
We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.
1.2 Registered number type
Registration number
ABN 13655717169
1.3 ASX issuer code
COV
1.4 The announcement is
New announcement
1.5 Date of this announcement
29/12/2025
Appendix 2A - Application for quotation of securities
2 / 6
Appendix 2A - Application for quotation of securities
==> picture [21 x 22] intentionally omitted <==
Part 2 - Type of Issue
2.1 The +securities to be quoted are:
+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted
2.2 The +class of +securities to be quoted is:
Additional +securities in a class that is already quoted on ASX ("existing class")
Appendix 2A - Application for quotation of securities
3 / 6
Appendix 2A - Application for quotation of securities
==> picture [21 x 22] intentionally omitted <==
Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B
Existing +securities converting into additional +securities in an existing class FROM (Existing Class) ASX +security code and description COVAN : OPTION EXPIRING 22-AUG-2026 EX $0.30
TO (Existing Class) ASX +security code and description COV : ORDINARY FULLY PAID
| Please state the number of options | The first date the options were | The last date the options were |
|---|---|---|
| that were exercised or other | exercised or other +convertible | exercised or other +convertible |
| +convertible securities that were | securities were converted | securities were converted |
| converted | 29/12/2025 | 29/12/2025 |
| 28,750 | ||
| Is this all of the options or other +convertible securities on issue of that type | (ie have all of those options now been | |
| exercised or have all of those convertible securities now been converted)? | ||
| No |
The right of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by: An issue of new +securities The underlying +securities being received by the holder are: Intended to be, but are not yet, quoted by ASX Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme? No
Issue date
29/12/2025
Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes
Appendix 2A - Application for quotation of securities
4 / 6
Appendix 2A - Application for quotation of securities
Issue details
==> picture [21 x 22] intentionally omitted <==
Number of +securities to be quoted 28,750 Are the +securities being issued for a cash consideration? Yes In what currency is the cash consideration being paid? What is the issue price per +security? AUD - Australian Dollar AUD 0.30000000 Any other information the entity wishes to provide about the +securities to be quoted
Appendix 2A - Application for quotation of securities
5 / 6
Appendix 2A - Application for quotation of securities
==> picture [21 x 22] intentionally omitted <==
Part 4 - Issued capital following quotation
Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:
The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.
4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)
+securities subject of this application) |
|
|---|---|
| Total number of | |
| ASX +security code and description | +securities on issue |
| COV : ORDINARY FULLY PAID | 128,528,751 |
| 4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX) | |
| Total number of | |
| ASX +security code and description | +securities on issue |
| COVAN : OPTION EXPIRING 22-AUG-2026 EX $0.30 | 13,971,250 |
| COVAO : PERFORMANCE RIGHTS | 1,500,000 |
| COVAP : OPTION EXPIRING 23-APR-2028 EX $0.50 | 1,250,000 |
4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)
Appendix 2A - Application for quotation of securities
6 / 6